Prevalence and risk factors for colonisation and infection with carbapenem-resistant Enterobacterales in intensive care units: A prospective multicentre study
Yi-Le Wu,Xiao-Qian Hu,De-Quan Wu,Ruo-Jie Li,Xue-Ping Wang,Jin Zhang,Zhou Liu,Wen-Wen Chu,Xi Zhu,Wen-Hui Zhang,Xue Zhao,Zi-Shu Guan,Yun-Lan Jiang,Jin-Feng Wu,Zhuo Cui,Ju Zhang,Jia Li,Ru-Mei Wang,Shi-Hua Shen,Chao-Yang Cai,Hai-Bin Zhu,Quan Jiang,Jing Zhang,Jia-Lan Niu,Xian-Peng Xiong,Zhen Tian,Jian-She Zhang,Jun-Lin Zhang,Li-Ling Tang,An-Yun Liu,Cheng-Xiang Wang,Ming-Zhu Ni,Jing-Jing Jiang,Xi-Yao Yang,Min Yang,Qiang Zhou
DOI: https://doi.org/10.1016/j.iccn.2023.103491
IF: 5.3
2023-07-22
Intensive and Critical Care Nursing
Abstract:Objectives This study aimed to investigate the prevalence and risk factors for carbapenem-resistant Enterobacterales colonisation/infection at admission and acquisition among patients admitted to the intensive care unit. Research methodology/design A prospective and multicentre study. Setting This study was conducted in 24 intensive care units in Anhui, China. Main outcome measures Demographic and clinical data were collected, and rectal carbapenem-resistant Enterobacterales colonisation was detected by active screening. Multivariate logistic regression models were used to analyse factors associated with colonisation/infection with carbapenem-resistant Enterobacterales at admission and acquisition during the intensive care unit stay. Results There were 1133 intensive care unit patients included in this study. In total, 5.9% of patients with carbapenem-resistant Enterobacterales colonisation/infection at admission, and of which 56.7% were colonisations. Besides, 8.5% of patients acquired carbapenem-resistant Enterobacterales colonisation/infection during the intensive care stay, and of which 67.6% were colonisations. At admission, transfer from another hospital, admission to an intensive care unit within one year, colonisation/infection/epidemiological link with carbapenem-resistant Enterobacterales within one year, and exposure to any antibiotics within three months were risk factors for colonisation/infection with carbapenem-resistant Enterobacterales . During the intensive care stay, renal disease, an epidemiological link with carbapenem-resistant Enterobacterales , exposure to carbapenems and beta-lactams/beta-lactamase inhibitors, and intensive care stay of three weeks or longer were associated with acquisition. Conclusion The prevalence of colonisation/infection with carbapenem-resistant Enterobacterales in intensive care units is of great concern and should be monitored systematically. Particularly for the 8.5% prevalence of carbapenem-resistant Enterobacterales acquisition during the intensive care stay needs enhanced infection prevention and control measures in these setting. Surveillance of colonisation/infection with carbapenem-resistant Enterobacterales at admission and during the patient's stay represents an early identification tool to prevent further transmission of carbapenem-resistant Enterobacterales . Implications for clinical practice Carbapenem-resistant Enterobacterales colonization screening at admission and during the patient's stay is an important tool to control carbapenem-resistant Enterobacterales spread in intensive care units.
nursing